Literature DB >> 32155645

Necrotizing Enterocolitis: The Future.

Josef Neu1.   

Abstract

Progress in our understanding of the pathophysiology, prevention and treatment of necrotizing enterocolitis (NEC) has been hampered for many reasons. Included among these is the fact that what we are calling "NEC" is likely to represent different disease processes, which need to be delineated before evaluating individual pathogenic mechanisms and attempting to develop predictive and diagnostic biomarkers. Treatment is also likely to be hampered because not all of the different entities called "NEC" will respond to the same regimen. In this review, some of these entities will be discussed in more detail, with suggestions for refining our approach toward improving methods for their diagnosis, prevention and treatment.
© 2020 S. Karger AG, Basel.

Entities:  

Keywords:  Definition; Necrotizing enterocolitis; Pathophysiology; Prevention; Treatment

Year:  2020        PMID: 32155645     DOI: 10.1159/000506866

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  17 in total

Review 1.  MiR-1290: a potential therapeutic target for regenerative medicine or diagnosis and treatment of non-malignant diseases.

Authors:  Mohammad Reza Kalhori; Masoud Soleimani; Kheirollah Yari; Mahmoudreza Moradi; Amir Ali Kalhori
Journal:  Clin Exp Med       Date:  2022-07-08       Impact factor: 3.984

Review 2.  Predicting clinical outcomes using artificial intelligence and machine learning in neonatal intensive care units: a systematic review.

Authors:  Ryan M McAdams; Ravneet Kaur; Yao Sun; Harlieen Bindra; Su Jin Cho; Harpreet Singh
Journal:  J Perinatol       Date:  2022-05-13       Impact factor: 2.521

3.  Three-hourly versus two-hourly feeding interval in stable preterm infants: an updated systematic review and meta-analysis of randomized controlled trials.

Authors:  Jogender Kumar; Jitendra Meena; Pradeep Debata; MJeeva Sankar; Praveen Kumar; Arvind Shenoi
Journal:  Eur J Pediatr       Date:  2022-02-11       Impact factor: 3.183

Review 4.  Enteral Feeding Interventions in the Prevention of Necrotizing Enterocolitis: A Systematic Review of Experimental and Clinical Studies.

Authors:  Ilse H de Lange; Charlotte van Gorp; Laurens D Eeftinck Schattenkerk; Wim G van Gemert; Joep P M Derikx; Tim G A M Wolfs
Journal:  Nutrients       Date:  2021-05-19       Impact factor: 5.717

5.  Galectin-4 as a Novel Biomarker of Neonatal Intestinal Injury.

Authors:  Jennifer B Fundora; Jie Zhu; Lisa R Yanek; Mitzi Go; Fauzia Shakeel; Sandra S Brooks; Jun Yang; David J Hackam; Allen D Everett; Darla R Shores
Journal:  Dig Dis Sci       Date:  2021-03-18       Impact factor: 3.199

6.  Hyponatremia at the onset of necrotizing enterocolitis is associated with intestinal surgery and higher mortality.

Authors:  Elena Palleri; Veronica Frimmel; Urban Fläring; Marco Bartocci; Tomas Wester
Journal:  Eur J Pediatr       Date:  2021-12-21       Impact factor: 3.183

7.  Probiotics mixture reinforces barrier function to ameliorate necrotizing enterocolitis by regulating PXR-JNK pathway.

Authors:  Xiuhao Zhao; Jin Zhou; Wenhua Liang; Qingfeng Sheng; Li Lu; Tong Chen; Jianglong Chen; Kezhe Tan; Zhibao Lv
Journal:  Cell Biosci       Date:  2021-01-19       Impact factor: 7.133

8.  Association of Surgical Necrotizing Enterocolitis and its Timing with Retinopathy of Prematurity.

Authors:  Jennifer B Fundora; Gil Binenbaum; Lauren Tomlinson; Yinxi Yu; Gui-Shuang Ying; Akhil Maheshwari; Pamela Donohue
Journal:  Am J Perinatol       Date:  2021-08-03       Impact factor: 1.862

9.  Perinatal development of innate immune topology.

Authors:  Philipp Henneke; Katrin Kierdorf; Lindsey J Hall; Markus Sperandio; Mathias Hornef
Journal:  Elife       Date:  2021-05-25       Impact factor: 8.140

10.  Fecal High-Mobility Group Box 1 as a Marker of Early Stage of Necrotizing Enterocolitis in Preterm Neonates.

Authors:  Roberta Vitali; Gianluca Terrin; Francesca Palone; Ilaria Laudadio; Salvatore Cucchiara; Giovanni Boscarino; Maria Di Chiara; Laura Stronati
Journal:  Front Pediatr       Date:  2021-06-10       Impact factor: 3.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.